| Expression pattern: |
UP |
| Associated gene: |
FAK, c-Met, HGF, nAchRalpha7, EGFR |
| Associated microRNA: |
- |
| Biological function: |
Promotes EMT and invasion/metastatic potential; increases drug resistance in lung adenocarcinoma cells. |
| Molecular mechanism: |
HGF/c-Met and FAK signaling regulate cirRNA CCDC66 expression; cirRNA CCDC66 is suggested to adsorb miRNA and may act on the ER where miRNA maturation/adsorption occurs, contributing to EMT marker expression and invasion. |
| Biological pathway or process: |
EMT (promotes); invasion (promotes); metastasis (promotes); drug resistance (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Transfection; Transwell Assay; Bioinformatics Analysis |
| Clinical significance: |
- |
| Description: |
cirRNA CCDC66 is up-regulated in lung adenocarcinoma specimens/cells and is regulated by HGF/c-Met and FAK (and negatively by nAchRalpha7). Functional perturbation shows it promotes EMT-marker expression and invasion, and is implicated in drug-resistance phenotypes in LADC cells. |
| Confidence score: |
0.3963 |